Evidence-Based Complementary and Alternative Medicine / 2023 / Article / Tab 3 / Research Article
Behavioral Prevention, Treatment, and Rehabilitation of Using Western and Chinese Medicines or Herbal Products among the Public in Response to COVID-19 in Hong Kong: A Cross-Sectional Study Table 3 Chinese medicines or Western medicines used for COVID-19 depend on age.
Prevention Treatment Rehabilitation Row total Chinese medicines 18–37 Frequency (expected) (χ 2 ) 31 (34.0) (0.27) 58 (60.5) (0.10) 58 (52.5) (0.58) 147 Row (%) 21.1% 39.5% 39.5% 47.3% Column (%) 43.1% 45.3% 52.3% 38–57 Frequency (expected) (χ 2 ) 29 (25.5) (0.49) 46 (45.27) (0.01) 35 (39.3) (0.46) 110 Row (%) 26.4% 41.8% 31.8% 35.4% Column (%) 40.3% 35.9% 31.5% 58 or above Frequency (expected) (χ 2 ) 12 (12.5) (0.02) 24 (22.2) (0.14) 18 (19.27) (0.08) 54 Row (%) 22.2% 44.4% 33.3% 17.4% Column (%) 16.7% 18.8% 16.2% Column total 72 128 111 311 23.2% 41.2% 35.7% 100% Chi-square test χ 2 : 2.168— DF: 4 Western medicines 18–37 Frequency (expected) (χ 2 ) 51 (55.4) (0.35) 90 (86.9) (0.11) 18 (16.7) (0.11) 159 Row (%) 32.1% 56.6% 11.3% 59.6% Column (%) 54.8% 61.6% 64.3% 38–57 Frequency (expected) (χ 2 ) 35 (29.5) (0.98) 42 (46.5) (0.43) 8 (8.91) (0.09) 85 Row (%) 41.2% 49.4% 9.4% 31.8% Column (%) 37.6% 28.8% 28.6% 58 or above Frequency (expected) (χ 2 ) 7 (8.01) (0.13) 14 (12.6) (0.16) 2 (2.41) (0.07) 23 Row (%) 30.4% 60.9% 8.7% 8.6% Column (%) 7.5% 9.6% 7.1% Column total 93 146 28 267 34.8% 54.7% 10.5% 100% Chi-square test χ 2 : 2.427— DF: 4
